| Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes TF ADVANCE Collaborative Group, Patel A, MacMahon S New England Journal of Medicine 358 (24), 2560-72, 2008 | 9619 | 2008 |
| The transcriptional landscape of the mammalian genome P Carninci, T Kasukawa, S Katayama, J Gough, MC Frith, N Maeda, ... science 309 (5740), 1559-1563, 2005 | 3901 | 2005 |
| Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs RIKEN Genome Exploration Research Group Phase I Team: Carninci P. 2 Hayatsu ... Nature 420 (6915), 563-573, 2002 | 2062 | 2002 |
| Vaccine adjuvants: current state and future trends N Petrovsky, JC Aguilar Immunology and cell biology 82 (5), 488-496, 2004 | 1257 | 2004 |
| The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line Nature genetics 41 (5), 553-562, 2009 | 474 | 2009 |
| Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma cortisol and therapeutic implications N Petrovsky, P McNair, LC Harrison Cytokine 10 (4), 307-312, 1998 | 375 | 1998 |
| Technologies for enhanced efficacy of DNA vaccines F Saade, N Petrovsky Expert review of vaccines 11 (2), 189-209, 2012 | 346 | 2012 |
| Inulin-a versatile polysaccharide with multiple pharmaceutical and food chemical uses T Barclay, M Ginic-Markovic, P Cooper, N Petrovsky Journal of Excipients and Food Chemicals 1 (3), 1132, 2016 | 343 | 2016 |
| Will blockchain technology revolutionize excipient supply chain management? S Apte, N Petrovsky Journal of Excipients and Food Chemicals 7 (3), 2016 | 330 | 2016 |
| The chronobiology of human cytokine production N Petrovsky, LC Harrison International reviews of immunology 16 (5-6), 635-649, 1998 | 279 | 1998 |
| Molecular mechanisms for enhanced DNA vaccine immunogenicity L Li, N Petrovsky Expert review of vaccines 15 (3), 313-329, 2016 | 271 | 2016 |
| Comparative safety of vaccine adjuvants: a summary of current evidence and future needs N Petrovsky Drug safety 38 (11), 1059-1074, 2015 | 268 | 2015 |
| Towards a unified model of neuroendocrine–immune interaction N Petrovsky Immunology and cell biology 79 (4), 350-357, 2001 | 258 | 2001 |
| The future of human DNA vaccines L Li, F Saade, N Petrovsky Journal of biotechnology 162 (2-3), 171-182, 2012 | 230 | 2012 |
| Diurnal rhythmicity of human cytokine production: a dynamic disequilibrium in T helper cell type 1/T helper cell type 2 balance? N Petrovsky, LC Harrison Journal of immunology (Baltimore, Md.: 1950) 158 (11), 5163-5168, 1997 | 225 | 1997 |
| Computational methods for prediction of T-cell epitopes—a framework for modelling, testing, and applications V Brusic, VB Bajic, N Petrovsky Methods 34 (4), 436-443, 2004 | 215 | 2004 |
| Review of polysaccharide particle-based functional drug delivery TG Barclay, CM Day, N Petrovsky, S Garg Carbohydrate polymers 221, 94-112, 2019 | 208 | 2019 |
| Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic … Y Honda-Okubo, D Barnard, CH Ong, BH Peng, CTK Tseng, N Petrovsky Journal of virology 89 (6), 2995-3007, 2015 | 195 | 2015 |
| Methods for prediction of peptide binding to MHC molecules: a comparative study K Yu, N Petrovsky, C Schönbach, JLY Koh, V Brusic Molecular medicine 8, 137-148, 2002 | 187 | 2002 |
| Carbohydrate-based immune adjuvants N Petrovsky, PD Cooper Expert review of vaccines 10 (4), 523-537, 2011 | 167 | 2011 |
